Global Glaucoma Treatment Market by Indication (Angle Closure Glaucoma, Congenital Glaucoma, Open Angle Glaucoma), Type (Alpha Agonist, Beta Blockers, Carbonic Anhydrase Inhibitors), Sales Channel - Forecast 2024-2030- Product Image

Sale

Global Glaucoma Treatment Market by Indication (Angle Closure Glaucoma, Congenital Glaucoma, Open Angle Glaucoma), Type (Alpha Agonist, Beta Blockers, Carbonic Anhydrase Inhibitors), Sales Channel - Forecast 2024-2030

Report
197 Pages
March 2024
Region: Global
360iResearch™
ID: 5305564

UP TO €846EUR$875USD£725GBP OFF until Dec 31^st 2024

The Glaucoma Treatment Market size was estimated at USD 6.73 billion in 2023, USD 7.31 billion in 2024, and is expected to grow at a CAGR of 8.94% to reach USD 12.27 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Glaucoma Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Glaucoma Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Glaucoma Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Accutome, Inc., Akorn Operating Company LLC, Alcon Vision LLC, Amorphex Therapeutics LLC, ASICO LLC, Bausch + Lomb Corporation, Bayer AG, Carl Zeiss Meditec AG, Fera Pharmaceuticals, LLC, Glaukos Corporation, Inotek Pharmaceuticals, Lumenis Be Ltd., Merck & Co, Inc., Mobius Therapeutics, LLC, NIDEK CO., LTD., Novartis AG, Ocular Therapeutix, Inc., Perrigo Company PLC, Pfizer, Inc., Quantel Medical, Santen Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., and Topcon Corporation.

Market Segmentation & Coverage

This research report categorizes the Glaucoma Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Indication
- Angle Closure Glaucoma
- Congenital Glaucoma
- Open Angle Glaucoma
- Secondary Glaucoma
Type
- Alpha Agonist
- Beta Blockers
- Carbonic Anhydrase Inhibitors
- Cholinergic
- Combined Medications
- Prostaglandin Analogs
Sales Channel
- Hospital Pharmacies
- Online Sales
- Retail Pharmacies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Glaucoma Treatment Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Glaucoma Treatment Market?
What are the technology trends and regulatory frameworks in the Glaucoma Treatment Market?
What is the market share of the leading vendors in the Glaucoma Treatment Market?
Which modes and strategic moves are suitable for entering the Glaucoma Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Glaucoma Treatment Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing geriatric population coupled with rising incidences of glaucoma
5.1.1.2. Growing government and pharmaceutical organizations initiatives to increase awareness on glaucoma
5.1.1.3. Potential rise in the use of smart gadgets and screen time among the population
5.1.2. Restraints
5.1.2.1. Lack of early diagnosis in underdeveloped economies
5.1.3. Opportunities
5.1.3.1. Ongoing technological advancement with eye drops
5.1.3.2. Increasing research and development activities from pharmaceutical and
biotechnological companies for glaucoma treatment
5.1.4. Challenges
5.1.4.1. Concerns associated with drug recalls
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Glaucoma Treatment Market, by Indication

6.1. Introduction
6.2. Angle Closure Glaucoma
6.3. Congenital Glaucoma
6.4. Open Angle Glaucoma
6.5. Secondary Glaucoma

7. Glaucoma Treatment Market, by Type

7.1. Introduction
7.2. Alpha Agonist
7.3. Beta Blockers
7.4. Carbonic Anhydrase Inhibitors
7.5. Cholinergic
7.6. Combined Medications
7.7. Prostaglandin Analogs

8. Glaucoma Treatment Market, by Sales Channel

8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Sales
8.4. Retail Pharmacies

9. Americas Glaucoma Treatment Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Glaucoma Treatment Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Glaucoma Treatment Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. AbbVie Inc.
13.1.2. Accutome, Inc.
13.1.3. Akorn Operating Company LLC
13.1.4. Alcon Vision LLC
13.1.5. Amorphex Therapeutics LLC
13.1.6. ASICO LLC
13.1.7. Bausch + Lomb Corporation
13.1.8. Bayer AG
13.1.9. Carl Zeiss Meditec AG
13.1.10. Fera Pharmaceuticals, LLC
13.1.11. Glaukos Corporation
13.1.12. Inotek Pharmaceuticals
13.1.13. Lumenis Be Ltd.
13.1.14. Merck & Co, Inc.
13.1.15. Mobius Therapeutics, LLC
13.1.16. NIDEK CO., LTD.
13.1.17. Novartis AG
13.1.18. Ocular Therapeutix, Inc.
13.1.19. Perrigo Company PLC
13.1.20. Pfizer, Inc.
13.1.21. Quantel Medical
13.1.22. Santen Pharmaceutical Co., Ltd.
13.1.23. Teva Pharmaceutical Industries Ltd.
13.1.24. Topcon Corporation
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLAUCOMA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLAUCOMA TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLAUCOMA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLAUCOMA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLAUCOMA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLAUCOMA TREATMENT MARKET DYNAMICS
FIGURE 7. GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
FIGURE 12. GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS GLAUCOMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS GLAUCOMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES GLAUCOMA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES GLAUCOMA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC GLAUCOMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC GLAUCOMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. GLAUCOMA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. GLAUCOMA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. GLAUCOMA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLAUCOMA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 6. GLAUCOMA TREATMENT MARKET SIZE, BY ANGLE CLOSURE GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. GLAUCOMA TREATMENT MARKET SIZE, BY CONGENITAL GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLAUCOMA TREATMENT MARKET SIZE, BY OPEN ANGLE GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLAUCOMA TREATMENT MARKET SIZE, BY SECONDARY GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLAUCOMA TREATMENT MARKET SIZE, BY ALPHA AGONIST, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLAUCOMA TREATMENT MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLAUCOMA TREATMENT MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLAUCOMA TREATMENT MARKET SIZE, BY CHOLINERGIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLAUCOMA TREATMENT MARKET SIZE, BY COMBINED MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLAUCOMA TREATMENT MARKET SIZE, BY PROSTAGLANDIN ANALOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 18. GLAUCOMA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLAUCOMA TREATMENT MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLAUCOMA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS GLAUCOMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. CANADA GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 32. CANADA GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. MEXICO GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. MEXICO GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. MEXICO GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES GLAUCOMA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC GLAUCOMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. CHINA GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. CHINA GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. CHINA GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. INDIA GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. INDIA GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDIA GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. JAPAN GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. JAPAN GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. JAPAN GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. THAILAND GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 76. THAILAND GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. THAILAND GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. DENMARK GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. DENMARK GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. EGYPT GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. EGYPT GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. EGYPT GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. FINLAND GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 92. FINLAND GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. FINLAND GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. FRANCE GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. FRANCE GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. FRANCE GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. GERMANY GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. GERMANY GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. ITALY GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. ITALY GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. ITALY GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. NORWAY GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. NORWAY GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. NORWAY GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. POLAND GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 116. POLAND GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. POLAND GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. QATAR GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. QATAR GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. QATAR GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. SPAIN GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. SPAIN GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. SPAIN GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. TURKEY GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. TURKEY GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. TURKEY GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. GLAUCOMA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 149. GLAUCOMA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. GLAUCOMA TREATMENT MARKET LICENSE & PRICING

Companies Mentioned

AbbVie Inc.
Accutome, Inc.
Akorn Operating Company LLC
Alcon Vision LLC
Amorphex Therapeutics LLC
ASICO LLC
Bausch + Lomb Corporation
Bayer AG
Carl Zeiss Meditec AG
Fera Pharmaceuticals, LLC
Glaukos Corporation
Inotek Pharmaceuticals
Lumenis Be Ltd.
Merck & Co, Inc.
Mobius Therapeutics, LLC
NIDEK CO., LTD.
Novartis AG
Ocular Therapeutix, Inc.
Perrigo Company PLC
Pfizer, Inc.
Quantel Medical
Santen Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
Topcon Corporation

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	197
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 7.31 Billion
Forecasted Market Value ( USD ) by 2030	$ 12.27 Billion
Compound Annual Growth Rate	8.9%
Regions Covered	Global
No. of Companies Mentioned	24

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3263EUR$3,374USD£2,796GBP €3625EUR$3,749USD£3,107GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,542GBP €4593EUR$4,749USD£3,936GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5004EUR$5,174USD£4,288GBP €5560EUR$5,749USD£4,765GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5874EUR$6,074USD£5,034GBP €6527EUR$6,749USD£5,594GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7615EUR$7,874USD£6,526GBP €8461EUR$8,749USD£7,251GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Glaucoma Surgery Devices Market Size, Share & Trends Analysis Report By Product (Laser Systems, Diamond Knives), By Surgery Method (MIGS, Laser Surgery), By End-use (Hospitals, Ophthalmic Clinics), And Segment Forecasts, 2023 - 2030

Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size, Share & Trends Analysis Report by Product (Valves, Glaucoma Drainage Implant), Surgery Method, End-use, Region, and Segment Forecast 2024-2030

Glaucoma Market Insight, Epidemiology and Market Forecast - 2032

Global Glaucoma Surgery Devices Market by Product (Algerbrush, Diamond Knives, Forceps), Surgery Method (Laser Surgery, Minimal Invasive Glaucoma Surgery, Traditional Glaucoma Surgery), End-User - Forecast 2024-2030

Global Glaucoma Treatment Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

About the Glaucoma Drug Market